Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz Sells 20,000 Shares

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $46.71, for a total transaction of $934,200.00. Following the completion of the transaction, the director now directly owns 3,540,857 shares of the company’s stock, valued at approximately $165,393,430.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Simulations Plus Price Performance

NASDAQ SLP traded up $0.77 on Tuesday, hitting $46.95. The stock had a trading volume of 207,144 shares, compared to its average volume of 102,393. The stock has a market cap of $938.53 million, a price-to-earnings ratio of 86.58 and a beta of 0.72. Simulations Plus, Inc. has a 52-week low of $32.69 and a 52-week high of $52.69. The business’s fifty day moving average price is $47.80 and its 200 day moving average price is $44.14.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, April 3rd. The technology company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. Simulations Plus had a net margin of 16.22% and a return on equity of 7.95%. The firm had revenue of $18.31 million for the quarter, compared to analyst estimates of $17.31 million. During the same period in the previous year, the company earned $0.20 earnings per share. The business’s quarterly revenue was up 16.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Simulations Plus, Inc. will post 0.55 EPS for the current year.

Simulations Plus Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, May 6th. Shareholders of record on Monday, April 29th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 0.51%. The ex-dividend date of this dividend was Friday, April 26th. Simulations Plus’s payout ratio is 45.28%.

Institutional Investors Weigh In On Simulations Plus

Several hedge funds have recently added to or reduced their stakes in SLP. Conestoga Capital Advisors LLC raised its position in shares of Simulations Plus by 12.5% in the fourth quarter. Conestoga Capital Advisors LLC now owns 2,259,176 shares of the technology company’s stock worth $101,098,000 after acquiring an additional 251,299 shares during the period. Vanguard Group Inc. raised its position in shares of Simulations Plus by 1.1% in the first quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock worth $46,710,000 after acquiring an additional 12,636 shares during the period. Ranger Investment Management L.P. raised its position in shares of Simulations Plus by 1.4% in the fourth quarter. Ranger Investment Management L.P. now owns 931,132 shares of the technology company’s stock worth $41,668,000 after acquiring an additional 12,505 shares during the period. Wasatch Advisors LP raised its position in shares of Simulations Plus by 36.5% in the first quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock worth $15,707,000 after acquiring an additional 102,135 shares during the period. Finally, Kennedy Capital Management LLC raised its position in shares of Simulations Plus by 3.2% in the first quarter. Kennedy Capital Management LLC now owns 229,439 shares of the technology company’s stock worth $9,441,000 after acquiring an additional 7,077 shares during the period. 78.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. William Blair assumed coverage on shares of Simulations Plus in a research note on Friday. They issued an “outperform” rating for the company. Craig Hallum lifted their price target on shares of Simulations Plus from $51.00 to $56.00 and gave the stock a “buy” rating in a report on Thursday, June 13th. Finally, Oppenheimer lifted their price target on shares of Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a report on Thursday, June 13th.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.